HawaiiSB 2262025–2026 Regular Session (Year 2)Senate

RELATING TO PRESCRIPTION DRUGS.

Sponsored By: Brandon J.C. Elefante (Democratic)

In Committee

Summary

Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

Health InsurancePrescription DrugsStep Therapy ProtocolClinical Review CriteriaClinical Practice GuidelinesExceptionsHHS, CPN

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Brandon J.C. Elefante

    Democratic • Senate

Cosponsors

  • Stanley Chang

    Democratic • Senate

  • Lynn DeCoite

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Carried over to 2026 Regular Session.

    12/8/2025
  2. Referred to HHS, CPN.

    1/17/2025Senate
  3. Introduced and passed First Reading.

    1/15/2025Senate
  4. Pending Introduction.

    1/13/2025Senate

Bill Text

Related Bills

Back to State Legislation